# Filing Detail

Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-21-006611
Filing Date
2021-05-14
Accepted
2021-05-14 17:24:03
Documents
25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS/A | 1834133
2 |  | filename2.htm | EX-3.1 | 122278
3 |  | filename3.htm | EX-3.2 | 61860
4 |  | filename4.htm | EX-4.1 | 274380
5 |  | filename5.htm | EX-10.7 | 52061
6 |  | filename6.htm | EX-10.8 | 52478
7 |  | filename7.htm | EX-10.9 | 52059
8 | GRAPHIC | g104413g00q15.jpg | GRAPHIC | 177155
9 | GRAPHIC | g104413g03a03.jpg | GRAPHIC | 147367
10 | GRAPHIC | g104413g04q02.jpg | GRAPHIC | 138433
11 | GRAPHIC | g104413g11t00.jpg | GRAPHIC | 138632
12 | GRAPHIC | g104413g20a69.jpg | GRAPHIC | 80846
13 | GRAPHIC | g104413g21g20.jpg | GRAPHIC | 45080
14 | GRAPHIC | g104413g22y47.jpg | GRAPHIC | 64941
15 | GRAPHIC | g104413g30s55.jpg | GRAPHIC | 49280
16 | GRAPHIC | g104413g51i08.jpg | GRAPHIC | 106124
17 | GRAPHIC | g104413g52c34.jpg | GRAPHIC | 47434
18 | GRAPHIC | g104413g56t67.jpg | GRAPHIC | 83359
19 | GRAPHIC | g104413g64m48.jpg | GRAPHIC | 90608
20 | GRAPHIC | g104413g71z61.jpg | GRAPHIC | 52225
21 | GRAPHIC | g104413g82e41.jpg | GRAPHIC | 64605
22 | GRAPHIC | g104413g89k52.jpg | GRAPHIC | 88136
23 | GRAPHIC | g104413g89w33.jpg | GRAPHIC | 87529
24 | GRAPHIC | g104413g92p79.jpg | GRAPHIC | 201333
25 | GRAPHIC | g104413g98x03.jpg | GRAPHIC | 85330
| Complete submission text file | 0000950123-21-006611.txt |  | 4847902

Mailing Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551
Business Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-04647 | Film No.: 21926160
SIC: 2836 Biological Products, (No Diagnostic Substances)